Cargando…

Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice

Diabetic cardiomyopathy (DCM) is an important cause of heart failure in diabetic patients. The present study sought to explore the potential effects of dihydromyricetin (DHM) on DCM and its possible mechanism. A diabetic model was induced by intraperitoneal injection of streptozotocin (STZ) in C57BL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Bin, Lin, Jie, Luo, Jian, Han, Dong, Fan, Miaomiao, Guo, Tao, Tao, Ling, Yuan, Ming, Yi, Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379084/ https://www.ncbi.nlm.nih.gov/pubmed/28421194 http://dx.doi.org/10.1155/2017/3764370

Ejemplares similares

Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
por: Liu, Wenjuan, et al.
Publicado: (2018)

Forskolin Protected against Streptozotocin-Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Cardiac Fibrosis in Mice
por: Zhang, Xu, et al.
Publicado: (2021)

Edaravone Protect against Retinal Damage in Streptozotocin-Induced Diabetic Mice
por: Yuan, Dongqing, et al.
Publicado: (2014)

Nesfatin-1 protects against diabetic cardiomyopathy in the streptozotocin-induced diabetic mouse model via the p38-MAPK pathway
por: Fan, Zhanwei, et al.
Publicado: (2022)

Protective Effects of Leukemia Inhibitory Factor on Retinal Vasculature and Cells in Streptozotocin-induced Diabetic Mice
por: Yang, Xiu-Fen, et al.
Publicado: (2018)

Dihydromyricetin Protects against Bone Loss in Ovariectomized Mice by Suppressing Osteoclast Activity
por: Zhao, Libo, et al.
Publicado: (2017)

Galectin-3 Inhibition Ameliorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice
por: Zhu, Ning, et al.
Publicado: (2022)

Research progress of dihydromyricetin in the treatment of diabetes mellitus
por: Wang, Ziyuan, et al.
Publicado: (2023)

Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes
por: Wu, Meng, et al.
Publicado: (2018)

Dihydromyricetin Attenuates Diabetic Cardiomyopathy by Inhibiting Oxidative Stress, Inflammation and Necroptosis via Sirtuin 3 Activation
por: Chen, Yun, et al.
Publicado: (2023)

Protective Effect of Dihydromyricetin Against Lipopolysaccharide-Induced Acute Kidney Injury in a Rat Model
por: Wang, Jun-Tao, et al.
Publicado: (2016)

Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats
por: Fan, Yuyan, et al.
Publicado: (2019)

Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R
por: ALTamimi, Jozaa Z., et al.
Publicado: (2021)

NOX2 Deficiency Protects Against Streptozotocin-Induced β-Cell Destruction and Development of Diabetes in Mice
por: Xiang, Fu-Li, et al.
Publicado: (2010)

Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses
por: Jiang, Zhaohui, et al.
Publicado: (2020)

Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats
por: Atta, Mustafa S., et al.
Publicado: (2018)

Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice
por: Cai, Jian, et al.
Publicado: (2014)

Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice
por: Waasdorp, Maaike, et al.
Publicado: (2016)

The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy
por: Jiang, Tao, et al.
Publicado: (2010)

Syringic Acid Attenuates Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
por: Sabahi, Zahra, et al.
Publicado: (2021)

Protective Effects of Dihydromyricetin against •OH-Induced Mesenchymal Stem Cells Damage and Mechanistic Chemistry
por: Li, Xican, et al.
Publicado: (2016)

Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice
por: Peng, Lulu, et al.
Publicado: (2022)

Protective effects of Tat-DJ-1 protein against streptozotocin-induced diabetes in a mice model
por: Yeo, Hyeon Ji, et al.
Publicado: (2018)

Thymulin and peroxiredoxin 6 have protective effects against streptozotocin-induced type 1 diabetes in mice
por: Novoselova, Elena G, et al.
Publicado: (2021)

Abnormal gut microbiota composition contributes to cognitive dysfunction in streptozotocin-induced diabetic mice
por: Yu, Fan, et al.
Publicado: (2019)

Pyridostigmine Protects Against Diabetic Cardiomyopathy by Regulating Vagal Activity, Gut Microbiota, and Branched-Chain Amino Acid Catabolism in Diabetic Mice
por: Yang, Yang, et al.
Publicado: (2021)

Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function
por: Zhang, Yingmei, et al.
Publicado: (2012)

Dihydromyricetin hexaacetate
por: Li, Wei, et al.
Publicado: (2010)

New Method for Extracting and Purifying Dihydromyricetin from Ampelopsis grossedentata
por: Hu, Hongchao, et al.
Publicado: (2020)

Myricitrin Alleviates Oxidative Stress-induced Inflammation and Apoptosis and Protects Mice against Diabetic Cardiomyopathy
por: Zhang, Bin, et al.
Publicado: (2017)

Dihydromyricetin Improves Endothelial Dysfunction in Diabetic Mice via Oxidative Stress Inhibition in a SIRT3-Dependent Manner
por: Hua, Yu-Yun, et al.
Publicado: (2020)

Recombinant Reg3β protein protects against streptozotocin-induced β-cell damage and diabetes
por: Luo, Chen, et al.
Publicado: (2016)

Aldosterone Antagonists in Monotherapy Are Protective against Streptozotocin-Induced Diabetic Nephropathy in Rats
por: Banki, Nora F., et al.
Publicado: (2012)

Dendropanax morbifera Protects against Renal Fibrosis in Streptozotocin-Induced Diabetic Rats
por: Sachan, Richa, et al.
Publicado: (2020)

Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice
por: Zhang, Xiuli, et al.
Publicado: (2016)

Deletion of RasGRF1 Attenuated Interstitial Fibrosis in Streptozotocin-Induced Diabetic Cardiomyopathy in Mice through Affecting Inflammation and Oxidative Stress
por: Tsai, Tzu-Hsien, et al.
Publicado: (2018)

Cathepsin B deteriorates diabetic cardiomyopathy induced by streptozotocin via promoting NLRP3-mediated pyroptosis
por: Liu, Chen, et al.
Publicado: (2022)

Cardio-Protective Role of Gingerol along with Prominent Anti-Diabetic Cardiomyopathy Action in A Streptozotocin-Induced Diabetes Mellitus Rat Model
por: Yu, Li-Ya, et al.
Publicado: (2017)

Protective Effects of Chromium Picolinate Against Diabetic-Induced Renal Dysfunction and Renal Fibrosis in Streptozotocin-Induced Diabetic Rats
por: Qi, Shan Shan, et al.
Publicado: (2020)

Glucose-lowering and hypolipidemic activities of polysaccharides from Cordyceps taii in streptozotocin-induced diabetic mice
por: Liu, Ru-Ming, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bpa8c8t4un0ekkgpreilu2ahgv